Elevated serum uric acid levels are associated with increased risk score and MACE development in patients with STEMI

Aim: Although the relationship between changes in serum uric acid (UA) levels and adverse events in ST segment elevation myocardial infarction (STEMI) patients is well known, the effect of an increase in UA levels on risk scores or major adverse cardiovascular event (MACE) development are not well established. In this study, we investigated the effects of ordinal changes in serum UA levels on adverse events and risk scores in STEMI patients.Material and Methods: The patients presenting with a diagnosis of STEMI and undergoing coronary angiography were included in the study. The patients were divided into seven groups evenly according to baseline UA levels and the effects of changes in UA levels on risk score and MACE were investigated.Results: A total 1200 STEMI patients was included in the study. The mean age of the patients was 62 years and 72% of them were males. While both Syntax score-II (SS-2) and Cadillac scores (CS) were lower among Group-1 and Group-4; SS-2, CS and development of MACE were markedly increased with an increase in UA levels.Conclusions: The UA levels in STEMI patients can be guiding for the clinician regarding the development of adverse event and patient-based intensive approaches should be considered in the patients with higher UA levels.

PDF

___

1. Liu CW, Liao PC, Chen KC, et al. Relationship of serum uric acid and Killip class on mortality after acute ST-segment elevation myocardial infarction and primary percutaneous coronary intervention. Int J Cardiology 2017;226:26-33.
2. Mandurino-Mirizzi A, Crimi G, Raineri C, et al. Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Cardiovasc Med 2018;19:240-6.
3. Baumann S, Huseynov A, Koepp J, et al. comparison of serum uric acid, bilirubin, and c-reactive protein as prognostic biomarkers of in-hospital mace between women and men with st-segment elevation myocardial infarction. Angiology 2016;67:272-80.
4. Foth C, Mountfort S. Myocardial infarction, acute, st elevation (STEMI). statpearls. treasure island (FL) 2018;16.
5. Task Force on the management of ST seamiot ESoC, Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-619.
6. Capodanno D, Caggegi A, Miano M, et al. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv 2011;4:287-97.
7. Tanboga IH, Topcu S, Aksakal E, et al. Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost 2014;20:716-22.
8. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009;5:50-6.
9. Farooq V, van Klaveren D, Steyerberg EW, et al. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 2013;381:639-50.
10. Karabag Y, Cagdas M, Rencuzogullari I, et al. Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction. Int J Cardiovasc Imag 2018;34:1165-75.
11. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. Jam Coll Cardiol 2005;45:1397-405.
12. Sgarbossa EB, Pinski SL, Barbagelata A, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators. N Engl J Med 1996;334:481-7.
13. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (esvs): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesendorsed by: the european stroke organization (eso)the task force for the diagnosis and treatment of peripheral arterial diseases of the european society of cardiology (esc) and of the european society for vascular surgery (esvs). Eur Heart J 2018;39:763-816.
14. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.
15. Aksu U, Gulcu O, Bilgi Z, et al. The association of the Syntax score II with carotid intima media thickness and epicardial fat tissue. Ind Heart J 2017;69:752-6.
16. Mendez-Eirin E, Flores-Rios X, Garcia-Lopez F, et al. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI. Rev Esp Cardiol (Engl Ed) 2012;65:227-33.
17. Kozieradzka A, Kaminski KA, Maciorkowska D, et al. GRACE, TIMI, Zwolle and CADILLAC risk scores-do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively? Int J Cardiol 2011;148:70-5.
18. Barbieri L, Verdoia M, Schaffer A, et al. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI. Nutr Metab Cardiovasc Dis 2015;25:181-6.
19. Kurtul A, Yarlioglues M, Murat SN, et al. Predictors of chronic total occlusion in nonculprit artery in patients with acute coronary syndrome: mean platelet volume and uric acid. Angiology 2015;66:553-9.
20. Uysal OK, Sahin DY, Duran M, et al. Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology 2014; 65:227-31.
21. Duran M, Kalay N, Akpek M, et al. High levels of serum uric acid predict severity of coronary artery disease in patients with acute coronary syndrome. Angiology 2012;63:448-52.
22. Duran M, Ornek E, Murat SN, et al. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology 2012;63:472-5.